Prolactin Receptor Polyclonal Antibody - Citations

Prolactin Receptor Polyclonal Antibody - Citations

View additional product information for Prolactin Receptor Polyclonal Antibody - Citations (344800)

Showing 3 product Citations

Citations & References
Abstract
Re-evaluation of the prolactin receptor expression in human breast cancer.
AuthorsGalsgaard ED, Rasmussen BB, Folkesson CG, Rasmussen LM, Berchtold MW, Christensen L, Panina S,
JournalJ Endocrinol
PubMed ID19153125
'The pituitary hormone PRL is involved in tumorigenesis in rodents and humans. PRL promotes proliferation, survival and migration of cancer cells acting via the PRL receptor (PRLR). Aiming to perform a large-scale immunohistochemical (IHC) screening of human mammary carcinomas for PRLR expression, we evaluated the specificity of commercially available anti-human ... More
Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.
AuthorsSchroeder MD, Brockman JL, Walker AM, Schuler LA,
JournalEndocrinology
PubMed ID12970160
Posttranslational modifications of prolactin (PRL), including phosphorylation, vary with physiologic state and alter biologic activity. In light of the growing evidence for a role for PRL in proliferation in mammary cancer, we examined the ability of a mimic of phosphorylated human PRL, S179D-PRL, to initiate signals to several pathways in ... More
Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue.
AuthorsLing C, Svensson L, Odén B, Weijdegård B, Edén B, Edén S, Billig H,
JournalJ Clin Endocrinol Metab
PubMed ID12679477
During lactation serum levels of prolactin (PRL) are elevated, and the activity of lipoprotein lipase (LPL) is decreased in the adipose tissue and increased in the mammary gland. However, PRL has been suggested to affect the adipose tissue in an indirect fashion during lactation. In the present study, we demonstrated ... More